Form 8-K · Current report
CVS Health 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0000064803
- Accession no.
- 0000064803-26-000097
Summary
It reported second-quarter 2026 total revenues of $106.1 billion, up 7.3% year-over-year, with GAAP diluted EPS of $2.31 and adjusted EPS of $2.58, and raised its full-year 2026 guidance for GAAP diluted EPS to $6.84–$7.04, adjusted EPS to $7.90–$8.10, and cash flow from operations to at least $11.5 billion. Chairman and CEO David Joyner said the company continues to deliver strong performance while maintaining a cautious view for the remainder of the year amid elevated cost trends and potential macro headwinds.
Key points
- Second-quarter GAAP diluted EPS rose to $2.31 from $0.80 a year earlier, and adjusted EPS rose to $2.58 from $1.81, driven mainly by improved adjusted operating income in the Health Care Benefits segment.
- The Health Care Benefits segment's medical benefit ratio improved to 87.4% from 89.9%, and medical membership was 26.0 million, consistent with March 31, 2026.
- CVS Health launched GLP-1 support offerings including a $29 MinuteClinic virtual visit and participation in the CMS Medicare GLP-1 Bridge program, which runs through December 31, 2027.
- Aetna launched a second-generation Aetna Claims Assist Manager that it says reduces processing time by over 20% for complex claims requiring manual review.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On August 5, 2026, CVS Health Corporation issued a press release announcing results for the three months ended June 30, 2026. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 2.02 by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.